laitimes

Global Interleukin Market Size and Future Growth Research-Luyi Market Strategy

author:LPInformation

Summary of content

The global interleukin market size was valued at approximately USD 42.5 million in 2023 and is expected to reach USD 82.6 million by 2030, registering a compound annual growth rate (CAGR) of 10.2% during 2024-2030.

The core manufacturers of interleukin in the world are Bio-Techne, Cytiva and Lonza, and the top three manufacturers account for about 43% of the global share. North America is the largest market with a share of about 52%, followed by Europe and Asia-Pacific with 28% and 17% respectively. In terms of product type, pharmaceutical grade is the largest segment, accounting for about 73% of the share, while in terms of downstream, medical is the largest downstream segment, accounting for 73% of the share.

By Product Type:

Pharmaceutical grade

other

By Application:

medical

Media supplements

scientific research

Major regions/countries covered in this article:

Americas region

United States

Canada

Mexico

Brazil

Asia pacific

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

United Kingdom

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

Gulf countries

This article mainly covers the following companies:

Cytiva

Bio-Techne

Lonza

Sartorius CellGenix

Thermo Fisher Scientific

Miltényi Biotec

Akron Biotech

Sino Biological

Creative Bioarray

Table of contents of the text

1 Scope of the study

1.1 Definitions

1.2 The year covered in this article

1.3 Research Objectives

1.4 Research Methodology

1.5 Research process and data sources

1.6 Economic indicators

2 Industry Overview

2.1 Overall global scale

2.1.1 Overall size of the global interleukin industry 2019-2030

2.1.2 Global Interleukin Market Size by Major Regions, 2019, 2023 & 2030

2.1.3 Global Interleukin Market Size by Major Countries, 2019, 2023 & 2030

2.2 Interleukin classification

2.2.1 Pharmaceutical grade

2.2.2 Miscellaneous

2.3 Interleukin Category Market Size

2.4 Interleukin downstream applications

2.4.1 Medical

2.4.2 Media supplements

2.4.3 Scientific research

2.5 Global Market Size by Application Segment

3 Global market competition pattern

3.1 Global Interleukin Revenue by Major Manufacturers

3.1.1 Global Interleukin Revenue by Major Manufacturers (2019-2024)

3.1.2 Global Interleukin Revenue Share by Key Manufacturers (2019-2024)

3.2 Global major manufacturers of interleukin product types and headquarters locations

3.2.1 The headquarters of the world's major manufacturers of interleukin

3.2.2 Global Key Manufacturers by Interleukin Product Type

3.3 Industry concentration analysis

3.3.1 Analysis of the global competitive situation

3.3.2 全球白细胞介素行业集中度分析(CR3, CR5 and CR10)&(2019-2024)

3.4 Potential Industry Entrants

3.5 Industry mergers and acquisitions and expansion

4 Global major regional scale analysis

4.1 Global Interleukin Market Size by Key Regions (2019-2024)

4.2 Global Interleukin Market Size by Major Countries (2019-2024)

4.2.1 Global Interleukin Revenue by Major Countries (2019-2024)

4.3 Interleukin revenue and growth rate in the Americas

4.4 Asia-Pacific interleukin revenue and growth rate

4.5 Europe interleukin revenue and growth rate

4.6 Middle East and Africa Interleukin Revenue and Growth Rate

5 Americas

5.1 Interleukin Industry Size by Major Countries in the Americas (2019-2024)

5.2 Interleukin classification revenue in the Americas (2019-2024)

5.3 Revenue by App in the Americas

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 Asia-Pacific

6.1 Asia-Pacific Interleukin Industry Size by Major Regions (2019-2024)

6.2 Asia-Pacific Interleukin Classification Income

6.3 Asia-Pacific revenue by application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 CHINA TAIWAN

7 Europe

7.1 Interleukin Industry Size by Major Countries in Europe (2019-2024)

7.2 European Interleukin Classification Income

7.3 Revenue by app in Europe

7.4 Germany

7.5 France

7.6 United Kingdom

7.7 Italy

7.8 Russia

8 Middle East and Africa

8.1 Middle East & Africa Interleukin Industry Size (2019-2024)

8.2 Middle East and Africa Interleukin Classification Income

8.3 Middle East & Africa Revenue by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 Gulf Area States

9 Industry trends, drivers and challenges

9.1 Industry Development Drivers

9.2 Challenges and Risks Faced by the Industry

9.3 Industry Development Trends

10 Global interleukin market size forecast by major regions

10.1 Global Interleukin Market Size Forecast by Major Regions

10.2 Americas Major Countries Forecast (2025-2030)

10.3 Asia-Pacific Key Countries Forecast (2025-2030)

10.4 Major European Countries Forecast (2025-2030)

10.5 Middle East & Africa Key Countries Forecasts (2025-2030)

10.6 Global Interleukin Forecast by Product Type (2025-2030)

10.7 Global Application Forecast (2025-2030)

11 Core Company Profile

11.1 Cytiva

11.1.1 Basic Cytiva Information

11.1.2 Cytiva Interleukin Products and Services

11.1.3 Cytiva Interleukin Revenue, Gross Margin and Market Share (2019-2024)

11.1.4 Cytiva's Main Business

11.1.5 Cytiva Update

11.2 Bio-Techne

11.2.1 Bio-Techne基本信息

11.2.2 Bio-Techne Interleukin Products and Services

11.2.3 Bio-Techne 白细胞介素收入、毛利率及市场份额(2019-2024)

11.2.4 Bio-Techne主要业务

11.2.5 Bio-Techne最新发展动态

11.3 Lonza

11.3.1 Lonza Basic Information

11.3.2 Lonza Interleukin Products and Services

11.3.3 Lonza Interleukin Revenue, Gross Margin and Market Share (2019-2024)

11.3.4 Lonza Main Business

11.3.5 Lonza Update

11.4 Sartorius CellGenix

11.4.1 Sartorius CellGenix基本信息

11.4.2 Sartorius CellGenix interleukin products and services

11.4.3 Sartorius CellGenix 白细胞介素收入、毛利率及市场份额(2019-2024)

11.4.4 Sartorius CellGenix主要业务

11.4.5 Sartorius CellGenix最新发展动态

11.5 Thermo Fisher Scientific

11.5.1 Thermo Fisher Scientific基本信息

11.5.2 Thermo Fisher Scientific 白细胞介素产品及服务

11.5.3 Thermo Fisher Scientific 白细胞介素收入、毛利率及市场份额(2019-2024)

11.5.4 Thermo Fisher Scientific主要业务

11.5.5 Thermo Fisher Scientific最新发展动态

11.6 Miltényi Biotec

11.6.1 Miltenyi Biotec基本信息

11.6.2 Miltenyi Biotec Interleukin Products and Services

11.6.3 Miltenyi Biotec Interleukin Revenue, Gross Margin and Market Share (2019-2024)

11.6.4 Miltenyi Biotec's main business

11.6.5 Miltenyi Biotec Update

11.7 Akron Biotech

11.7.1 Akron Biotech基本信息

11.7.2 Akron Biotech Interleukin Products and Services

11.7.3 Akron Biotech Interleukin Revenue, Gross Margin and Market Share (2019-2024)

11.7.4 Akron Biotech主要业务

11.7.5 Akron Biotech最新发展动态

11.8 Sino Biological

11.8.1 Sino Biological基本信息

11.8.2 Sino Biological interleukin products and services

11.8.3 Sino Biological 白细胞介素收入、毛利率及市场份额(2019-2024)

11.8.4 Sino Biological主要业务

11.8.5 Sino Biological最新发展动态

11.9 Creative Bioarray

11.9.1 Creative Bioarray基本信息

11.9.2 Creative Bioarray interleukin products and services

11.9.3 Creative Bioarray Interleukin Revenue, Gross Margin and Market Share (2019-2024)

11.9.4 Creative Bioarray主要业务

11.9.5 Creative Bioarray最新发展动态

12 Report Summary

Table of Contents of Charts

Table of Contents

Table 1: Global Interleukin Market Size by Key Regions (2019, 2023 & 2030) & (USD Million)

Table 2: Global Interleukin Market Size by Key Countries (2019, 2023 & 2030) & (USD Million)

Table 3: Global Interleukin Revenue by Product Type (2019-2024) & (USD Million)

Table 4: Global Interleukin Revenue Share by Product Type (2019-2024)

Table 5: Global Revenue by Application (2019-2024) & (USD Million)

Table 6: Global Revenue Share by Application (2019-2024)

Table 7: Global Interleukin Revenue by Key Manufacturers (2019-2024) & (USD Million)

Table 8: Global Interleukin Revenue Share by Key Manufacturers (2019-2024)

Table 9: Global Major Manufacturers of Interleukin Headquarters and Market Distribution

Table 10: Global Key Manufacturers by Interleukin Product Type

表 11: 全球白细胞介素行业集中度分析(CR3, CR5 and CR10)&(2019-2024)

Table 12: Potential entrants in the industry

Table 13: Industry M&A and capacity expansion

Table 14: Global Interleukin Revenue by Key Regions (2019-2024) & (USD Million)

Table 15: Global Interleukin Revenue Share by Key Regions (2019-2024)

Table 16: Global Interleukin Revenue by Major Countries (2019-2024) & (USD Million)

Table 17: Global Interleukin Revenue Share by Key Countries (2019-2024)

Table 18: Interleukin Revenue by Major Countries in the Americas (2019-2024) & (USD Million)

Table 19: Interleukin Classification Revenue of the Americas (2019-2024) & (USD million)

Table 20: Americas Revenue by Application (2019-2024) & (USD Million)

Table 21: Asia-Pacific Interleukin Revenue by Key Regions, 2019-2024 & (USD Million)

Table 22: Asia-Pacific Interleukin Classification Revenue (2019-2024) & (USD Million)

Table 23: Asia-Pacific Revenue by Application (2019-2024) & (USD Million)

Table 24: Interleukin Revenue by Major Countries in Europe (2019-2024) & (USD Million)

Table 25: European Interleukin Classification Revenue (2019-2024) & (USD Million)

Table 26: Europe Revenue by Application (2019-2024) & (USD Million)

Table 27: Middle East & Africa Interleukin Revenue by Major Countries (2019-2024) & (USD Million)

Table 28: Middle East & Africa Interleukin Classification Revenue (2019-2024) & (USD Million)

Table 29: Middle East & Africa Revenue by Application (2019-2024) & (USD Million)

Table 30: Drivers of the interleukin industry development

Table 31: Challenges and risks faced by the interleukin industry

Table 32: Interleukin industry trends

Table 33: Global Interleukin Revenue by Key Regions (2025-2030) & (USD Million)

Table 34: Interleukin Revenue Forecast by Major Countries in the Americas (2025-2030) & (USD Million)

Table 35: Asia-Pacific Key Regional Interleukin Revenue Forecast (2025-2030) & (USD Million)

Table 36: Interleukin Revenue Forecast by Major Countries in Europe (2025-2030) & (USD Million)

Table 37: Middle East & Africa Interleukin Revenue Forecast by Key Countries (2025-2030) & (USD Million)

Table 38: Global Interleukin Revenue Forecast by Product Type (2025-2030) & (USD Million)

Table 39: Global Revenue Forecast by Application (2025-2030) & (USD Million)

Table 40: Global Revenue Share Forecast by Application (2025-2030)

Table 41: Cytiva Basic Information, Company Type, Market Segment, and Competitors

Table 42: Cytiva interleukin products and services

Table 43: Cytiva Interleukin Revenue (USD Million), Gross Margin and Market Share (2019-2024)

Table 44: Cytiva's main business

Table 45: Recent developments in Cytiva

Table 46: Bio-Techne Basic Information, Company Type, Market Segment, and Competitors

Table 47: Bio-Techne interleukin products and services

Table 48: Bio-Techne Interleukin Revenue (USD Million), Gross Margin and Market Share (2019-2024)

表 49: Bio-Techne主要业务

表 50: Bio-Techne最新发展动态

Table 51: Lonza Basic Information, Company Type, Market Region, and Competitors

Table 52: Lonza interleukin products and services

Table 53: Lonza Interleukin Revenue (USD Million), Gross Margin and Market Share (2019-2024)

Table 54: Lonza's main business

Table 55: Recent developments at Lonza

Table 56: Sartorius CellGenix Basic Information, Company Type, Market Segment, and Competitors

Table 57: Sartorius CellGenix interleukin products and services

Table 58: Sartorius CellGenix Interleukin Revenue (USD Million), Gross Margin and Market Share (2019-2024)

表 59: Sartorius CellGenix主要业务

表 60: Sartorius CellGenix最新发展动态

Table 61: Thermo Fisher Scientific Basic Information, Company Type, Market Segment, and Competitors

表 62: Thermo Fisher Scientific 白细胞介素产品及服务

表 63: Thermo Fisher Scientific 白细胞介素收入(百万美元)、毛利率及市场份额(2019-2024)

表 64: Thermo Fisher Scientific主要业务

表 65: Thermo Fisher Scientific最新发展动态

Table 66: Miltenyi Biotec Basic Information, Company Type, Market Segment and Competitors

Table 67: Miltenyi Biotec interleukin products and services

Table 68: Miltenyi Biotec Interleukin Revenue (USD Million), Gross Margin and Market Share (2019-2024)

Table 69: Miltenyi Biotec's main activities

Table 70: Recent developments at Miltenyi Biotec

Table 71: Akron Biotech Basic Information, Company Type, Market Region, and Competitors

Table 72: Akron Biotech Interleukin Products and Services

Table 73: Akron Biotech Interleukin Revenue (USD Million), Gross Margin and Market Share (2019-2024)

表 74: Akron Biotech主要业务

Table 75: Akron Biotech最新发展动态

Table 76: Sino Biological Basic Information, Company Type, Market Segment and Competitors

Table 77: Sino Biological interleukin products and services

Table 78: Sino Biological Interleukin Revenue (USD Million), Gross Margin and Market Share (2019-2024)

表 79: Sino Biological主要业务

表 80: Sino Biological最新发展动态

Table 81: Creative Bioarray Basic Information, Company Type, Market Region, and Competitors

Table 82: Creative Bioarray interleukin products and services

Table 83: Creative Bioarray Interleukin Revenue (USD Million), Gross Margin and Market Share (2019-2024)

表 84: Creative Bioarray主要业务

Table 85: Recent Developments in the Creative Bioarray

Table of Contents of Charts

Figure 1: Interleukin product image

Figure 2: The year covered in this article

Figure 3: Study Objectives

Figure 4: Research methodology

Figure 5: Research process and data sources

Figure 6: Global Interleukin Revenue and Growth Rate 2019-2030 (USD Million)

Figure 7: Global Interleukin Market Size by Key Regions (2019, 2023 > 2030)& (USD Million)

Figure 8: Global Interleukin Market Share by Key Countries (2023)

Figure 9: Global Interleukin Market Share by Key Countries (2019, 2023 > 2030)

Figure 10: Pharmaceutical-grade product image

Figure 11: Additional product images

Figure 12: Global Interleukin Revenue Share by Product Type (2019-2024)

Figure 13: Medical

Figure 14: Media supplementation

Figure 15: Scientific research

Figure 16: Global revenue share by app in 2023

Figure 17: Global Interleukin Revenue by Key Manufacturers (USD Million) in 2023

Figure 18: Global Interleukin Revenue Share by Key Manufacturers in 2023

Figure 19: Global Interleukin revenue share by key regions, 2023

Figure 20: Interleukin Revenue in the Americas (2019-2024) & (USD Million)

Figure 21: Asia-Pacific Interleukin Revenue (2019-2024) & (USD Million)

Figure 22: European Interleukin Revenue (2019-2024) & (USD Million)

Figure 23: Middle East & Africa Interleukin Revenue (2019-2024) & (USD Million)

Figure 24: Interleukin Revenue Share by Major Countries in the Americas (2019-2024)

Figure 25: Interleukin Revenue in the Americas by Product Type (2019-2024)

Figure 26: Americas Revenue Share by Application (2019-2024)

Figure 27: U.S. Interleukin Revenue and Growth Rate (2019-2024) & (USD Million)

Figure 28: Canada Interleukin Revenue and Growth Rate (2019-2024) & (USD Million)

Figure 29: Mexico Interleukin Revenue and Growth Rate (2019-2024) & (USD Million)

Figure 30: Brazil Interleukin Revenue and Growth Rate (2019-2024) & (USD Million)

Figure 31: Asia-Pacific Key Regional Interleukin Revenue Share (2019-2024)

Figure 32: Asia-Pacific Interleukin Revenue by Product Type (2019-2024)

Figure 33: Asia-Pacific Revenue Share by Application (2019-2024)

Figure 34: China Interleukin Revenue and Growth Rate (2019-2024) & (USD Million)

Figure 35: Japan Interleukin Revenue and Growth Rate (2019-2024) & (USD Million)

Figure 36: South Korea Interleukin Revenue and Growth Rate (2019-2024) & (USD Million)

Figure 37: Southeast Asia Interleukin Revenue and Growth Rate (2019-2024) & (USD Million)

Figure 38: India Interleukin Revenue and Growth Rate (2019-2024) & (USD Million)

Figure 39: Australia Interleukin Revenue and Growth Rate (2019-2024) & (USD Million)

Figure 40: Taiwan Interleukin Revenue and Growth Rate (2019-2024) & (USD Million)

Figure 41: Share of Interleukin Revenue by Key Countries in Europe (2019-2024)

Figure 42: Europe Interleukin Revenue by Product Type (2019-2024)

Figure 43: Europe Revenue Share by Application (2019-2024)

Figure 44: Germany Interleukin Revenue and Growth Rate (2019-2024) & (USD Million)

Figure 45: France Interleukin Revenue and Growth Rate (2019-2024) & (USD Million)

Figure 46: UK Interleukin Revenue and Growth Rate (2019-2024) & (USD Million)

Figure 47: Italy Interleukin Revenue and Growth Rate (2019-2024) & (USD Million)

Figure 48: Russia Interleukin Revenue and Growth Rate (2019-2024) & (USD Million)

Figure 49: Middle East & Africa Key Countries by Interleukin Revenue Share (2019-2024)

Figure 50: Middle East & Africa Interleukin Revenue by Product Type (2019-2024)

Figure 51: Middle East & Africa Revenue Share by Application (2019-2024)

Figure 52: Egyptian Interleukin Revenue and Growth Rate (2019-2024) & (USD Million)

Figure 53: South Africa Interleukin Revenue and Growth Rate (2019-2024) & (USD Million)

Figure 54: Israel Interleukin Revenue and Growth Rate (2019-2024) & (USD Million)

Figure 55: Turkey Interleukin Revenue and Growth Rate (2019-2024) & (USD Million)

Figure 56: Interleukin Revenue and Growth Rate in Gulf Countries (2019-2024) & (USD Million)

Figure 57: Global Interleukin Revenue Share by Key Regions (2025-2030)

Figure 58: Global Interleukin Revenue Share Forecast by Product Type (2025-2030)